|
WO2016112455A1
|
|
Heterocyclic compounds for cancer imaging and treatment and methods for their use
|
|
WO2016058080A1
|
|
Fluoro-chloro bisphenol ether compounds and methods for their use
|
|
WO2016058082A1
|
|
18f compounds for cancer imaging and methods for their use
|
|
WO2016000070A1
|
|
Hydrophobically derivatized hyperbranched polyglycerol for intravascular drug delivery
|
|
WO2015135082A1
|
|
Bradykinin receptor b1 targeting probes
|
|
WO2015100498A1
|
|
Compositions and methods for imaging cancer
|
|
WO2015085398A1
|
|
Matriptase variants associated with tumors
|
|
WO2015031984A1
|
|
Halogenated compounds for cancer imaging and treatment and methods for their use
|
|
US2015072021A1
|
|
Methods and Kits for Predicting Outcome and Methods and Kits for Treating Breast Cancer with Radiation Therapy
|
|
US2015010469A1
|
|
Bisphenol ether compounds with novel bridging groups and methods for their use
|
|
US2016074674A1
|
|
Combined respiration and cardiac gating for radiotherapy using electrical impedance technology
|
|
WO2014127484A1
|
|
Spike-in control nucleic acids for sample tracking
|
|
WO2014063257A1
|
|
Methods and apparatus for colonic neoplasia detection with high frequency raman spectra
|
|
WO2014043813A1
|
|
Immune repertoire profiling
|
|
CN104780944A
|
|
Compositions targeting bradykinin receptor B1 for medical imaging of cancer and other disorders
|
|
US2013336962A1
|
|
Aziridine bisphenol ethers and related compounds and methods for their use
|
|
WO2013149336A1
|
|
5-nitrofuran-2-carboxamide derivatives for inhibiting centrosomal clustering
|
|
US2013195843A1
|
|
Biomarkers for Non-Hodgkin Lymphomas and Uses Thereof
|
|
CN104136020A
|
|
Reprogramming effector protein interactions to correct epigenetic defects in cancer
|
|
WO2013086639A1
|
|
Mutations indicative of weaver syndrome
|
